Halothane hepatitis and the anaesthesiologist.
作者信息
Shipton E A, Kruger A E
出版信息
S Afr Med J. 1984 Jan 21;65(3):86-9.
PMID:6364393
Abstract
There is no longer any doubt that liver dysfunction following surgery and anaesthesia may sometimes be attributable to the inhalational anaesthetic agent halothane. Much controversy still surrounds the entity of halothane hepatitis, which continues to vex the practising anaesthesiologist. The incidence, causation, pathogenesis and diagnosis of halothane hepatitis are presented, and the safety and practicality of halothane administration in the presence of liver dysfunction are discussed.
摘要
相似文献
1
Halothane hepatitis and the anaesthesiologist.
S Afr Med J. 1984 Jan 21;65(3):86-9.
2
Halothane hepatitis: a critical review.氟烷性肝炎：批判性综述。
Anesth Analg. 1972 Jan-Feb;51(1):135-60.
3
[Halothane hepatitis].
Ann Fr Anesth Reanim. 1982;1(6):629-33. doi: 10.1016/S0750-7658(82)80106-8.
4
Halothane in the United States. An appraisal of the literature on "halothane hepatitis" and the American reaction to it.
Br J Anaesth. 1972 Sep;44(9):925-34. doi: 10.1093/bja/44.9.925.
5
Halothane, hypoxia, and hepatitis.
Lancet. 1978 Sep 23;2(8091):673. doi: 10.1016/s0140-6736(78)92774-5.
6
Halothane induced liver damage.
J Oslo City Hosp. 1973 Oct;23(10):157-66.
7
Halothane hepatitis: toxicity or hypersensitivity?
N Z Med J. 1985 Sep 25;98(787):793-6.
8
Halothane: clinical considerations.氟烷：临床考量
Int Anesthesiol Clin. 1974 Summer;12(2):73-84.
9
Halothane hepatitis revisited.
S Afr Med J. 1991 Sep 21;80(6):261-2.
10
Halothane in Britain today.当今英国的氟烷。
Br J Anaesth. 1972 Sep;44(9):919-24. doi: 10.1093/bja/44.9.919.
Zotero 插件